Question 1

What are the most cited papers from Teva Pharmaceuticals (Ireland)?

Accepted Answer

The most cited paper from Teva Pharmaceuticals (Ireland) is "Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients" (Henk W. Reesink, Gregory C. Fanning, Khalid Abou Farha et al., 2009), with 156 citations. Next come "Rapid Viral Response of Once-Daily Tmc435 plus Pegylated Interferon/Ribavirin in Hepatitis C Genotype-1 Patients: A Randomized Trial" (66) and "A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites" (61).

Question 2

Which research topics does Teva Pharmaceuticals (Ireland) publish most on?

Accepted Answer

By volume in 2022-now: Inhalation and Respiratory Drug Delivery, Seismic Imaging and Inversion Techniques, Nanoplatforms for cancer theranostics and Migraine and Headache Studies.

Question 3

Which fields of science does Teva Pharmaceuticals (Ireland) work in?

Accepted Answer

In all years, 68% of research at Teva Pharmaceuticals (Ireland) is in Health Sciences, 19% in Physical Sciences. Its largest fields are Medicine (68%), Engineering (11%), Earth and Planetary Sciences (7%). It does 1.6× the world's share of Health Sciences.

Question 4

Is Teva Pharmaceuticals (Ireland)'s research output growing?

Accepted Answer

Output in 2022-2025 was 10% lower than in 2018-2021.